RT Journal Article
SR Electronic
T1 Post SARS-CoV-2 cell mediated Immune profiles; Case studies
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.02.22276875
DO 10.1101/2022.07.02.22276875
A1 Rajveer Singh
A1 Velayutham Ravichandiran
A1 Dipanjan Ghosh
A1 Ujjaini Ray
A1 Sarbani Dasgupta
A1 Soma Dutta
A1 Aditi Saha
A1 Debabrota Roy
A1 Srinika Ghosh
A1 A. Somasundaram
A1 Pallab Dutta
A1 N K Ganguly
A1 Debatosh Datta
YR 2022
UL http://medrxiv.org/content/early/2022/07/05/2022.07.02.22276875.abstract
AB Cell-mediated immunity (CMI), which includes T-cells (both T helper and cytotoxic), is critical for effective antiviral defenses against coronavirus disease-2019 (COVID-19). To better understand the immunological characteristics of CD markers on T-cells in post-COVID-19 patients, we investigated the expression of differential CD markers in the patient groups in this study.Flow cytometry was used to quantify total lymphocyte count and assess the levels of expression of CD markers in the samples. The percentage of Lymphocytes decreased significantly in the post-SARS-COV-2 patients in comparison to normal subjects, which is usually happening in any viral infection. In contrast to that, expression of CD8 was increased in the patient group having long SARS-COV-2 infection with comorbid complications with respect to the normal individuals and long SARS-COV-2 infection without comorbid complications. This data revealed that the cellular immunological responses corroborated with an earlier report of COVID-19 infection were mediated by CD8 upregulation and cytotoxic T lymphocyte hyperactivation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by NIPER, Kolkata. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical clearance was done, by ethical committee at Apollo multispeciality hospital, Kolkata, following the ICMR guidelines.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript